DK2435443T3 - Aminopyrazoltriazolothiadiazolhæmmere af c-met-proteinkinase - Google Patents

Aminopyrazoltriazolothiadiazolhæmmere af c-met-proteinkinase

Info

Publication number
DK2435443T3
DK2435443T3 DK10721904.0T DK10721904T DK2435443T3 DK 2435443 T3 DK2435443 T3 DK 2435443T3 DK 10721904 T DK10721904 T DK 10721904T DK 2435443 T3 DK2435443 T3 DK 2435443T3
Authority
DK
Denmark
Prior art keywords
aminopyrazoltriazolothiadiazole
inhibitors
protein kinase
met protein
met
Prior art date
Application number
DK10721904.0T
Other languages
English (en)
Inventor
David Lauffer
Pan Li
Kira Mcginty
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42346870&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2435443(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharma filed Critical Vertex Pharma
Application granted granted Critical
Publication of DK2435443T3 publication Critical patent/DK2435443T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
DK10721904.0T 2009-05-28 2010-05-27 Aminopyrazoltriazolothiadiazolhæmmere af c-met-proteinkinase DK2435443T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18178609P 2009-05-28 2009-05-28
PCT/US2010/036312 WO2010138665A1 (en) 2009-05-28 2010-05-27 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase

Publications (1)

Publication Number Publication Date
DK2435443T3 true DK2435443T3 (da) 2013-10-28

Family

ID=42346870

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10721904.0T DK2435443T3 (da) 2009-05-28 2010-05-27 Aminopyrazoltriazolothiadiazolhæmmere af c-met-proteinkinase

Country Status (26)

Country Link
EP (1) EP2435443B1 (da)
JP (1) JP5686796B2 (da)
KR (1) KR20120030110A (da)
CN (1) CN102459283B (da)
AR (1) AR076617A1 (da)
AU (1) AU2010254055B2 (da)
BR (1) BRPI1012037A2 (da)
CA (1) CA2762190A1 (da)
CL (1) CL2011002946A1 (da)
DK (1) DK2435443T3 (da)
ES (1) ES2433090T3 (da)
HK (1) HK1169105A1 (da)
HR (1) HRP20130986T1 (da)
IL (1) IL216581A (da)
MX (1) MX2011012521A (da)
NZ (1) NZ596616A (da)
PL (1) PL2435443T3 (da)
PT (1) PT2435443E (da)
RS (1) RS53011B (da)
RU (1) RU2552993C2 (da)
SG (1) SG176574A1 (da)
SI (1) SI2435443T1 (da)
TW (1) TWI491614B (da)
UA (1) UA106082C2 (da)
WO (1) WO2010138665A1 (da)
ZA (1) ZA201108655B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012528185A (ja) * 2009-05-28 2012-11-12 バーテックス ファーマシューティカルズ インコーポレイテッド ｃ−Ｍｅｔタンパク質キナーゼの置換ピラゾール阻害剤
JP2013527195A (ja) * 2010-05-27 2013-06-27 バーテックス ファーマシューティカルズ インコーポレイテッド ｃ−Ｍｅｔプロテインキナーゼのアミノピラゾールトリアゾロチアジアゾールインヒビター
TR201113223A2 (tr) * 2011-12-29 2012-06-21 Koçak Farma İlaç Ve Ki̇mya Sanayi̇ A. Ş. Pemetrekset disodyum hazırlanmasına yönelik tek basamaklı işlem.
KR101373912B1 (ko) 2012-03-26 2014-03-13 중앙대학교 산학협력단 Ｓｈｐ－2의 활성을 특이적으로 저해하는 조성물 및 이의 제조방법
CN106924260B (zh) * 2015-12-31 2018-05-25 北京浦润奥生物科技有限责任公司 化合物在制备用于治疗脑胶质瘤的药物中的用途
CN109897054B (zh) * 2017-12-08 2021-12-10 中国药科大学 ***并噻二唑类c-Met激酶抑制剂的制备方法及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5716981A (en) 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
ZA200501536B (en) * 2002-08-14 2006-10-25 Vertex Pharma Protein kinase inhibitors and uses thereof
US7122548B2 (en) * 2003-07-02 2006-10-17 Sugen, Inc. Triazolotriazine compounds and uses thereof
JO2629B1 (en) * 2004-08-19 2012-06-24 افينتيس فارما سوتيكالز انك Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
CN101360748B (zh) * 2005-11-30 2012-05-30 沃泰克斯药物股份有限公司 c-MET抑制剂及其应用
CA2630884A1 (en) * 2005-11-30 2007-06-07 Vertex Pharmaceuticals Incorporated Inhibitors of c-met and uses thereof
NL2000613C2 (nl) * 2006-05-11 2007-11-20 Pfizer Prod Inc Triazoolpyrazinederivaten.
BRPI0812360A2 (pt) * 2007-05-21 2015-01-27 Sgx Pharmaceuticals Inc Compostos moduladores de quinase heterocíclica e método de modulação da atividade de uma proteína tirosina quinase
WO2010059668A1 (en) * 2008-11-19 2010-05-27 Vertex Pharmaceuticals Incorporated A triazolothiadiazole inhibitor of c-met protein kinase
JP2012528185A (ja) * 2009-05-28 2012-11-12 バーテックス ファーマシューティカルズ インコーポレイテッド ｃ−Ｍｅｔタンパク質キナーゼの置換ピラゾール阻害剤

Also Published As

Publication number Publication date
RU2011153613A (ru) 2013-07-10
UA106082C2 (uk) 2014-07-25
RU2552993C2 (ru) 2015-06-10
CL2011002946A1 (es) 2012-07-27
TW201100436A (en) 2011-01-01
AR076617A1 (es) 2011-06-22
CN102459283B (zh) 2014-11-12
IL216581A0 (en) 2012-02-29
EP2435443B1 (en) 2013-07-31
IL216581A (en) 2014-02-27
ES2433090T3 (es) 2013-12-09
PT2435443E (pt) 2013-10-31
EP2435443A1 (en) 2012-04-04
PL2435443T3 (pl) 2014-01-31
JP5686796B2 (ja) 2015-03-18
AU2010254055B2 (en) 2016-01-14
AU2010254055A1 (en) 2011-12-15
NZ596616A (en) 2013-05-31
HK1169105A1 (en) 2013-01-18
KR20120030110A (ko) 2012-03-27
ZA201108655B (en) 2013-01-30
RS53011B (en) 2014-04-30
SG176574A1 (en) 2012-01-30
BRPI1012037A2 (pt) 2016-05-17
CN102459283A (zh) 2012-05-16
HRP20130986T1 (hr) 2013-11-22
TWI491614B (zh) 2015-07-11
SI2435443T1 (sl) 2013-12-31
MX2011012521A (es) 2012-01-30
JP2012528186A (ja) 2012-11-12
WO2010138665A1 (en) 2010-12-02
CA2762190A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
CY2019009I1 (el) Αναστολεις πρωτεϊνικων κινασων
LTPA2019006I1 (lt) Junginiai ir kompozicijos kaip proteinkinazės inhibitoriai
SMT201600075B (it) Composto di diamminocarbossammide eterociclica
CO6950481A2 (es) Inhibidores de proteínas quinasas
BRPI0910668A2 (pt) inibidores de proteína quinases
DK2419429T3 (da) Imidazopyraziner som inhibitorer af proteinkinaser
DK3409278T3 (da) Heterocykliske proteinkinaseinhibitorer
BRPI1009112A2 (pt) inibidores de tirosina quinase de bruton
CO6970602A2 (es) Inhibidores de quinasa
CO6960542A2 (es) Polimorfos de inhibidores de cinasas
BRPI0918846A2 (pt) inibidores de cinase heterocíclica
DK2710007T3 (da) Kinasehæmmere
DK2848610T3 (da) Hæmmere af kinaseaktivitet
BR112014000653A2 (pt) inibidores de tirosina quinase de bruton
BR112012000525A2 (pt) inibidores da bace
BRPI0911228A2 (pt) compostos e composições como inibidores de proteínas quinase
BR112013029620A2 (pt) inibidores de tirosina quinase de bruton
DK2271642T3 (da) Pyridylinhibitorer af hedgehog signalering
DK2247592T3 (da) Pyrrolopyrazinkinaseinhibitors
ATE519763T1 (de) Pyrrolopyrazin-kinasehemmer
DK2260873T3 (da) Pcylering af proteiner
DK2526425T3 (da) Fremgangsmåde til diagnosticering af endometriel receptivitet
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
BRPI0920239A2 (pt) compostos heterocíclicos como inibidores de proteínas quinases
DK2111555T3 (da) Diagnosticering af præeklampsi